Arbutus Biopharma (ABUS) Stock Forecast for 2024–2028. Sell or Buy Prediction







Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

Arbutus Biopharma (ABUS) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 13, 2024 (07:58)

Sector: Healthcare

The share price of Arbutus Biopharma Corp. (ABUS) now

Latest session on the 12th of April for
Arbutus Biopharma Corp. is negative
Trading Volume: 666195
Open: 2.99 /  High: 3.03 /  Low: 2.9
What analysts predict: $4.4
52-week High/Low: $3.29 / $1.69

50/200 Day Moving Average: $2.701 / $2.237

This figure corresponds to the Average Price over the previous 50/200 days. For Arbutus Biopharma stocks, the 50-day moving average is the support level today.

For Arbutus Biopharma stocks, the 200-day moving average is the support level today.

Are you interested in Arbutus Biopharma Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arbutus Biopharma stock price in 2022, 2023, 2024, 2025, 2026. How much will one Arbutus Biopharma share be worth in 2022 - 2026?

When should I take profit in Arbutus Biopharma stock? When should I record a loss on Arbutus Biopharma stock? What are analysts' forecasts for Arbutus Biopharma stock? What is the future of Arbutus Biopharma stock? We forecast Arbutus Biopharma stock performance using neural networks based on historical data on Arbutus Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Arbutus Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Arbutus Biopharma shares. This happens once a day.


Historical and forecast chart of Arbutus Biopharma stock

The chart below shows the historical price of Arbutus Biopharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Arbutus Biopharma stock price can be found in the table below.

Long-term forecasts by years.

Arbutus Biopharma Corporation, a biopharmaceutical company, is engaged in the discovery, development and commercialization of a drug for patients with chronic hepatitis B virus (HBV) infection in the United States. Its HBV product portfolio consists of AB-836, a capsid inhibitor that can inhibit HBV replication by preventing the assembly of functional viral capsids; and AB-423, which is undergoing preclinical studies. The company is also developing RNAi preparations that use the RNA interference pathway, which allows a new approach to the treatment of diseases.

Arbutus Biopharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 15 3.02 2.99 3.09 3.18
Apr 16 3.06 3.01 3.09 2.72
Apr 17 3.09 3.05 3.15 3.09
Apr 18 3.12 3.06 3.15 3.03
Apr 19 3.11 3.06 3.15 3.14
Apr 20 3.09 3.05 3.15 3.24
Apr 21 3.12 3.05 3.15 3.28
Apr 22 3.10 3.03 3.15 4.02
Apr 23 3.18 3.15 3.20 1.61
Apr 24 3.21 3.15 3.27 3.92
Apr 25 3.15 3.12 3.22 3.37
Apr 26 3.14 3.12 3.19 2.27
Apr 27 3.18 3.11 3.22 3.50
Apr 28 3.24 3.21 3.28 2.09
Apr 29 3.26 3.22 3.31 2.80
Apr 30 3.30 3.28 3.36 2.57
May 01 3.30 3.24 3.36 3.88
May 02 3.30 3.27 3.35 2.36
May 03 3.30 3.22 3.38 4.79
May 04 3.29 3.24 3.33 2.90
May 05 3.30 3.28 3.36 2.54
May 06 3.27 3.21 3.30 2.78
May 07 3.27 3.24 3.31 2.00
May 08 3.34 3.28 3.40 3.66
May 09 3.30 3.23 3.32 2.88
May 10 3.33 3.27 3.39 3.67
May 11 3.34 3.31 3.41 2.75
May 12 3.33 3.25 3.37 3.69
May 13 3.26 3.20 3.30 3.30
May 14 3.20 3.14 3.27 4.16

Arbutus Biopharma Daily Price Targets


Arbutus Biopharma Stock Forecast 04-15-2024.

Forecast target price for 04-15-2024: $3.02.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.079%.
Pessimistic target level: 2.99
Optimistic target level: 3.09

Arbutus Biopharma Stock Forecast 04-16-2024.

Forecast target price for 04-16-2024: $3.06.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 2.646%.
Pessimistic target level: 3.01
Optimistic target level: 3.09

Arbutus Biopharma Stock Forecast 04-17-2024.

Forecast target price for 04-17-2024: $3.09.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.001%.
Pessimistic target level: 3.05
Optimistic target level: 3.15

Arbutus Biopharma Stock Forecast 04-18-2024.

Forecast target price for 04-18-2024: $3.12.
Positive dynamics for Arbutus Biopharma shares will prevail with possible volatility of 2.937%.
Pessimistic target level: 3.06
Optimistic target level: 3.15

Arbutus Biopharma Stock Forecast 04-19-2024.

Forecast target price for 04-19-2024: $3.11.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.042%.
Pessimistic target level: 3.06
Optimistic target level: 3.15

Arbutus Biopharma Stock Forecast 04-20-2024.

Forecast target price for 04-20-2024: $3.09.
Negative dynamics for Arbutus Biopharma shares will prevail with possible volatility of 3.143%.
Pessimistic target level: 3.05
Optimistic target level: 3.15

ABUS (ABUS) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Apr. 3.03 2.95 3.19 7.52
May. 3.25 3.18 3.42 7.10
Jun. 3.30 3.23 3.49 7.40
Jul. 3.27 3.13 3.48 9.90
Aug. 2.99 2.82 3.17 10.94
Sep. 2.95 2.75 3.15 12.49
Oct. 2.91 2.72 3.12 12.76
Nov. 2.94 2.81 3.08 8.75
Dec. 3.04 2.83 3.14 9.68

Arbutus Biopharma forecast for this year


Arbutus Biopharma Stock Prediction for Apr 2022

An uptrend is forecast for this month with an optimal target price of $3.03364. Pessimistic: $2.95. Optimistic: $3.19


Arbutus Biopharma Stock Prediction for May 2022

An uptrend is forecast for this month with an optimal target price of $3.25206. Pessimistic: $3.18. Optimistic: $3.42


Arbutus Biopharma Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $3.29596. Pessimistic: $3.23. Optimistic: $3.49


Arbutus Biopharma Stock Prediction for Jul 2022

An downtrend is forecast for this month with an optimal target price of $3.26927. Pessimistic: $3.13. Optimistic: $3.48


Arbutus Biopharma Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $2.9868. Pessimistic: $2.82. Optimistic: $3.17


Arbutus Biopharma Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $2.94917. Pessimistic: $2.75. Optimistic: $3.15


Arbutus Biopharma Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $2.9067. Pessimistic: $2.72. Optimistic: $3.12


Arbutus Biopharma Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $2.93809. Pessimistic: $2.81. Optimistic: $3.08


Arbutus Biopharma Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $3.04122. Pessimistic: $2.83. Optimistic: $3.14



Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 3.21 3.14 3.31 5.06
Feb 3.03 2.82 3.22 12.44
Mar 2.96 2.77 3.09 10.09
Apr 3.18 2.99 3.37 11.20
May 3.31 3.08 3.39 9.07
Jun 3.25 3.12 3.35 6.89
Jul 3.14 3.04 3.35 9.13
Aug 3.15 3.07 3.33 7.83
Sep 3.33 3.18 3.56 10.85
Oct 3.34 3.22 3.47 7.20
Nov 3.08 2.87 3.15 8.97
Dec 2.95 2.82 3.02 6.50

Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 3.06 2.94 3.20 8.26
Feb 2.81 2.75 2.90 5.23
Mar 2.80 2.71 2.93 7.41
Apr 2.77 2.63 2.96 11.11
May 2.98 2.89 3.09 6.58
Jun 2.85 2.76 2.99 7.80
Jul 2.76 2.57 2.95 12.87
Aug 2.86 2.79 3.05 8.59
Sep 2.90 2.80 3.01 7.11
Oct 2.71 2.58 2.86 9.96
Nov 2.75 2.66 2.85 6.43
Dec 2.70 2.56 2.76 7.47

Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 2.86 2.74 3.00 8.59
Feb 2.81 2.72 2.89 6.03
Mar 2.95 2.85 3.14 9.36
Apr 2.81 2.69 3.00 10.46
May 2.73 2.58 2.84 8.94
Jun 2.67 2.61 2.82 7.31
Jul 2.59 2.42 2.65 8.71
Aug 2.37 2.29 2.46 6.94
Sep 2.47 2.36 2.64 10.52
Oct 2.46 2.32 2.58 10.13
Nov 2.43 2.34 2.61 10.33
Dec 2.65 2.46 2.79 11.80

Arbutus Biopharma (ABUS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.59 2.40 2.67 9.96
Feb 2.57 2.44 2.74 10.89
Mar 2.73 2.61 2.85 8.30
Apr 2.78 2.73 2.91 6.20
May 2.69 2.51 2.74 8.40
Jun 2.76 2.67 2.84 6.04
Jul 2.80 2.60 2.87 9.55
Aug 2.71 2.65 2.82 6.06
Sep 2.59 2.50 2.75 8.90
Oct 2.51 2.41 2.67 9.49
Nov 2.54 2.42 2.66 9.04
Dec 2.73 2.56 2.86 10.38

Arbutus Biopharma information and performance

Arbutus Biopharma Address

100-8900 GLENLYON PARKWAY, BURNABY, BC, CA

Market Capitalization: 539 374 000 $

Market capitalization of the Arbutus Biopharma Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABUS shares in the company outstanding by the market price of one share.

EBITDA: -76 630 000 $

EBITDA of Arbutus Biopharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.44

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.657
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 22.83

Enterprise Value (EV) /Revenue

EV To EBITDA: -5.84

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 179492000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.